Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
This paper describes a case of early (7 months after transplant) cardiac allograft vasculopathy. This-43-year-old (CMV positive, EBV negative) female patient underwent an orthotopic heart transplant with a (CMV negative, EBV positive) donor heart.
Ashim Aggarwal +3 more
doaj +1 more source
Implications of Transitional Care Interventions on Hospital Readmissions in Patients With Destination Therapy Left Ventricular Assist Devices [PDF]
Background: The rising number of patients with a left ventricular assist device (LVAD) require care management to successfully transition home after implantation. These patients and their families need to manage their heart failure, and the complexities
Hirschman, Karen +3 more
core +1 more source
Biventricular assist devices and total artificial heart: Strategies and outcomes
In contrast to the advanced development of the left ventricular assist device (LVAD) therapy for advanced heart failure, the mechanical circulatory support (MCS) with biventricular assist device (BVAD) and total artificial heart (TAH) options remain ...
Taiyo Kuroda +5 more
doaj +1 more source
Relationship between device acceptance and patient-reported outcomes in left ventricular assist device (LVAD) recipients [PDF]
The number of Left Ventricular Assist Devices (LVADs) implanted each year is rising. Nevertheless, there are minimal data on device acceptance after LVAD implant, and on its relationship with patient-reported outcomes. We designed a cross-sectional study
Adamo, Luigi +7 more
core +2 more sources
Heart Failure Anticoagulation Teach-Back Education and Readmissions [PDF]
: Heart failure affects millions of Americans each year. Treatment of advanced heart failure with reduced ejection fraction and left ventricular failure is sometimes treated with implantation of a left-ventricular assist device.
core
Carcinoid Crisis–Induced Acute Systolic Heart Failure
Carcinoid crisis is a life-threatening manifestation of carcinoid syndrome characterized by profound autonomic instability in the setting of catecholamine release from stress, tumor manipulation, or anesthesia.
Manoj V. Maddali, MD +8 more
doaj +1 more source
Heart Rate Variability: A possible machine learning biomarker for mechanical circulatory device complications and heart recovery [PDF]
Cardiovascular disease continues to be the number one cause of death in the United States, with heart failure patients expected to increase to \u3e8 million by 2030.
Aras, Shravan +2 more
core +1 more source
Pulsatile Mechanical Heart Assist Device
In this paper is described an innovative, easy to reuse heart assist device implying low production and maintenance costs, which needs minimally invasive techniques for the connection to the arterial system and that assists the failing heart according to the counterpulsation principle as an eligible solution for developing countries but also in case of
Pleşoianu, F.A. +3 more
openaire +2 more sources
Considerations of valvular heart disease in children with ventricular assist devices
Ventricular assist devices have become a valuable tool in the treatment of heart failure in children. The use of ventricular assist devices has decreased mortality in children with end-stage heart failure awaiting transplant.
Ming-Sing Si +4 more
doaj +1 more source
BackgroundRepeat hospitalizations, complications, and psychosocial burdens are common in patients with left ventricular assist devices (LVAD). Specialist palliative care (sPC) involvement supports patients during decision-making until end-of-life. In the
Theresa Tenge +18 more
doaj +1 more source

